have you ever asked yourself —what is medicine for? my latest piece in BMJ Leader #MedTwitter bmjleader.bmj.com/content/leader…

Critical Dependence on Area in Relationship between ARMS2/HTRA1 Genotype and Faster Geographic Atrophy Enlargement: AREDS2 Report 33 ow.ly/5Hyb50PQSb3 Tiarnan Keenan

#AMIA2023 Calling recent PhD graduates! 🎓 Exciting news - I'm recruiting for several postdoc roles in AI and data science, specializing in NLP and medical image analysis. Check out booth 308 or DM Yale Biomedical Informatics & Data Science Yale School of Medicine Yale University. Retweets appreciated!

We are excited to announce another #RIWC24 speaker 🔔Tiarnan Keenan from NEI is a specialist in diagnostics, prevention and treatment of AMD. His research involves genetic and clinical studies as well as the use of Artificial Intelligence! 👉 shorturl.at/cPQS0

7. Geographic Atrophy in Age-Related Macular Degeneration: A Tale of Two Stages ophthalmologyscience.org/article/S2666-… #Science #Top102023

“Monitoring health conditions in the home environment is useful for chronic diseases requiring rapid intervention to decrease risk of irreversible vision loss, particularly in #AMD..." wrote Tiarnan Keenan (National Eye Institute) & Anat Loewenstein (Tel Aviv University). healio.com/news/optometry…

Reticular pseudodrusen in AMD is associated with degeneration of dark adaptation kinetics and outer retinal degeneration adding to our understanding of these lesions being associated with local changes and a widespread process. ow.ly/sgG950QxSwN

I’m advertising for a biostatistician (>= Masters level) to join my highly productive clinical research lab at the National Eye Institute, NIH (Bethesda, MD). Ophthalmology experience not required. In-person or hybrid. linkedin.com/hiring/jobs/38…

In a phase II clinical trial, a group assigned to oral minocycline, a microglial inhibitor, did not have slower geographic atrophy progression over 24 months compared with a 9-month run-in phase, in age-related macular degeneration. ja.ma/3IzP5J4

They first took off during Covid, but doctors soon realised the technology could be utilised to treat other conditions. As Dr Niall Keenan of West Herts Teaching Hospitals NHS Trust says: ‘We thought other patients could benefit’. [5/8]

In a phase II clinical trial, a group assigned to oral minocycline, a microglial inhibitor, did not have slower geographic atrophy progression over 24 months compared with a 9-month run-in phase, in age-related macular degeneration. ja.ma/3UnXKoP

The AREDS Age-Related Macular Degeneration (AMD) Severity Scale and associated 5 yr rates of progression to late disease have been modernized to include reticular pseudodrusen and to fit updated definitions of late AMD. ow.ly/6XVe50RqI81 Tiarnan Keenan

We’re pleased to announce an ARVO Special Interest Group (SIG) on Mathematical and Computational Ophthalmology, to be held via Zoom on Thursday 20th June from 9:00am-10:30am EST/EDT (= 2:00pm-3:30pm BST). ARVO ESMTB SMB - Society for Mathematical Biology @IMSR_UoB Systems Modelling & Quantitative Biomedicine

New study finds that a widely available oral supplement can slow progression of Geographic Atrophy by up to 55% over 3 years. #AMD Led by Tiarnan Keenan and team NIH NEI with co-author Pearse Keane of UCL Institute of Ophthalmology Moorfields Eye Hospital NHS Foundation Trust INSIGHTeyehub bit.ly/3LvlYrW

Can oral antioxidant supplements slow progression of geographic atrophy in AMD? New work from the NEI intramural program & collaborators suggests yes. Tiarnan Keenan NIH Intramural NIH, Emily Chew, Pearse Keane Amitha Domalpally Ophthalmology paper: aaojournal.org/article/S0161-…

New research has found that taking a daily vitamin and mineral supplement can slow the progression of geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD). Read more about this new AREDS2 research: macularsociety.org/about/media/ne…

New study in Ophthalmology shows that a daily, widely available antioxidant oral supplement can slow the progression of late-stage Dry Age-related Macular Degeneration #AMD. Read our latest #news item 👉tinyurl.com/mrxe2w87 INSIGHTeyehub | Moorfields Eye Hospital NHS Foundation Trust | UCL Institute of Ophthalmology Pearse Keane

Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration ow.ly/Oo1Q50SFeAX Tiarnan Keenan #ophthalmology